JKT 005
Alternative Names: JKT-005Latest Information Update: 09 May 2024
At a glance
- Originator JKT Biopharma
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Monkeypox
Most Recent Events
- 28 Mar 2024 Early research in Monkeypox in China (unspecified route), prior to March 2024 (JKT Biopharma pipeline, March 2024)